Jimenez Garcia LI, Asquel Caiza SD, Rogel Macas EI, Santodomingo Galindo AF, Dede Badillo GE, Nolasco Toledo A. Tumor-infiltrating lymphocyte (TIL) therapy for immunotherapy-refractory advanced melanoma: a systematic review of response and survival rates. IBEROJHR [Internet]. 20º de outubro de 2025 [citado 20º de setembro de 2026];5(2):392-9. Disponível em: https://health.iberojournals.com/index.php/IBEROJHR/article/view/845